Nexalin Technology, Inc. ( (NXL) ) has issued an announcement.
Nexalin Technology, Inc. has appointed Carolyn Shelton as their new Senior Vice President of Quality, Regulatory, and Clinical Affairs, tapping into her extensive experience from previous high-level roles in renowned health companies. With a substantial package including a $300,000 base salary, potential $40,000 bonuses, and stock options worth $60,000, Shelton’s appointment is a strategic move for Nexalin, aiming to leverage her expertise to achieve key performance milestones and drive company growth.
For a thorough assessment of NXL stock, go to TipRanks’ Stock Analysis page.
